DFNB9
5 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Safety, Tolerability, Efficacy of EA0010 in OTOF Patients With CI (NCT07752888) | Shanghai EmayGene Technology Co., Ltd | 2026-05-23 |
| A Study of EH002 Gene Therapy for Otoferlin Gene Mutation-mediated Hearing Loss (NCT06722170) | Yilai Shu | 2024-11-22 |
| A Phase I/II Clinical Trial With SENS-501 in Children Suffering From Severe to Profound Hearing Loss Due to Otoferlin (OTOF) Mutations (NCT06370351) | Sensorion | 2024-06-21 |
| An Investigator Initiated Study for OTOV101N+OTOV101C Injection (NCT05901480) | Otovia Therapeutics | 2023-06-26 |
| Natural History in Children up to 16 Years With Mild to Profound Hearing Loss Due to Mutations in GJB2 / OTOF Genes (NCT05402813) | Sensorion | 2022-11-18 |
Track DFNB9 automatically
Every clearance here is in the API, with alerts when new ones post.